Screening ultrasounds plus mammography may find more cancers in women who have breast dense tissue.
Editor's Note: An earlier version of this article stated that ultrasound screening for women with dense breasts results in fewer false positives. However, screening ultrasound increases the number of false positive biopsies. The article has been corrected.
Ultrasound screening for women with dense breasts detects a small number of additional cancers, compared to screening mammography alone, at the expense of a significant number of additional false positive biopsies, according to an article published in the American Journal of Obstetrics & Gynecology.
Researchers from the University of Washington in Seattle performed a comprehensive literature review of studies regarding breast cancer screening of women with dense breast tissue in the United States published from January 2000 and April 2013. Of 189 peer-reviewed publications, the researchers found 12 studies that fit their criteria.
[[{"type":"media","view_mode":"media_crop","fid":"25562","attributes":{"alt":"ultrasound","class":"media-image media-image-right","id":"media_crop_9441809144336","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"2340","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 134px; width: 200px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":" ","typeof":"foaf:Image"}}]]
The findings showed that when ultrasound was used in addition to mammography, physicians found an additional 0.3 to 7.7 cancers per 1,000 examinations (median 4.2) than when mammography was performed alone. There were also an additional 11.7 to 106.6 biopsies per 1,000 examinations (median 52.2).
“Most of the breast cancers identified by adjunctive US were small in size and node-negative in stage,” the authors wrote. “These are the cancers that are potentially curable by early detection and amenable to less aggressive treatment.” The researchers did point out, however, that some of the earlier staged cancers may have remained stable and been detected during the next regular screening mammography.
The researchers concluded that physicians should discuss with their patients how dense breast tissue can be a risk factor for breast cancer and whether the use of adjunctive screening, such as ultrasound, in addition to mammography screening may be beneficial for the patient.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.